2013 Nobel Laureate Michael Levitt is Insilico Medicine's latest Scientific Advisory Board addition in the pursuit of working interventions towards aging and aging-related disease. United with the board's current expertise, Dr. Levitt's backgroun ...
Please complete the following requested information to flag this post and report abuse, or offensive content. Your report will be reviewed within 24 hours. We will take appropriate action as described in Findit terms of use.